Council on the Kidney in Cardiovascular Disease (KCVD)

Message from the Chair

Janani Rangaswami, MD, FACP, FAHA

Welcome to the Council for the Kidney in Cardiovascular Disease (KCVD). Our Council strives to reduce cardiovascular-related disability and death through clinical, translational, and basic research, communication, advocacy, and education relevant to a) the role of the kidney in hypertension, b) the role of the kidney in cardiovascular diseases – this includes acute kidney injury and chronic kidney disease and its effects on heart disease, stroke, and peripheral vascular disease, c) the specific role of the kidney in diabetes-induced cardiovascular disease, and d) cardio-renal syndrome.

Janani Rangaswami, MD, FACP, FAHA
Chair, Council on Kidney in Cardiovascular Disease

KCVD Science News
The KCVD Council actively participates in the publication of scientific statements or guidelines that are important to our members. We've included those along with articles or research that cover topics of interest to our members below.

Mark Your Calendars for Hypertension 2024

September 5–8, 2024
Hilton Chicago | Chicago, Illinois

Looking for a new job opportunity? Check out our AHA Professional Member 2024 Featured Cardiovascular & Stroke Jobs Guide now!: View now to browse open positions from top healthcare employers!

black male doctor

AHA Professional Members are Difference Makers


Current AHA Research Grant and Funding Opportunities

Grant and funding opportunities are posted throughout the year. Check out a complete listing of current RFPs and apply to fund your research today.

Hypertension Journal cover


Hypertension is one of 14 AHA scientific journals. It represents the Councils on Hypertension and KCVD.

Scientific Sessions 2024

Scientific Sessions: November 16–18, 2024
McCormick Place Convention Center | Chicago, Illinois